ZCCHC8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.379900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.205400E-01
Normal-vs-Stage2
5.431800E-02
Normal-vs-Stage3
4.775600E-02
Normal-vs-Stage4
7.590200E-01
Stage1-vs-Stage2
2.111800E-01
Stage1-vs-Stage3
2.268400E-02
Stage1-vs-Stage4
5.951400E-01
Stage2-vs-Stage3
1.067630E-01
Stage2-vs-Stage4
9.799900E-02
Stage3-vs-Stage4
2.936000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.320400E-02
Normal-vs-AfricanAmerican
1.968400E-01
Normal-vs-Asian
8.135800E-02
Caucasian-vs-AfricanAmerican
7.173000E-01
Caucasian-vs-Asian
1.751400E-01
AfricanAmerican-vs-Asian
6.319800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.019790E-01
Normal-vs-Female
5.714100E-02
Male-vs-Female
7.101800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.212800E-01
Normal-vs-Age(41-60Yrs)
9.106200E-02
Normal-vs-Age(61-80Yrs)
7.857800E-02
Normal-vs-Age(81-100Yrs)
5.336100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.645000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.756800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.197200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.617700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.264300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.279600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.612200E-02
Normal-vs-Daily Drinker
4.926100E-02
Normal-vs-Weekly Drinker
1.472770E-01
Normal-vs-Occasional Drinker
2.301000E-01
Normal-vs-Social Drinker
1.751160E-01
Non Drinker-vs-Daily Drinker
8.493200E-01
Non Drinker-vs-Weekly Drinker
9.001400E-01
Non Drinker-vs-Occasional Drinker
6.364100E-02
Non Drinker-vs-Social Drinker
7.729500E-02
Daily Drinker-vs-Weekly Drinker
9.857400E-01
Daily Drinker-vs-Occasional Drinker
1.266830E-01
Daily Drinker-vs-Social Drinker
1.445220E-01
Weekly Drinker-vs-Occasional Drinker
2.386000E-01
Weekly Drinker-vs-Social Drinker
2.651600E-01
Occasional Drinker-vs-Social Drinker
9.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.444200E-02
Normal-vs-Grade 2
2.421600E-03
Normal-vs-Grade 3
6.863800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.755800E-01
Grade 1-vs-Grade 3
9.511600E-01
Grade 1-vs-Grade 4
5.444200E-02
Grade 2-vs-Grade 3
7.159600E-01
Grade 2-vs-Grade 4
2.421600E-03
Grade 3-vs-Grade 4
6.863800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.847800E-02
Normal-vs-NonDiabetic
7.125900E-02
Diabetic-vs-NonDiabetic
3.093800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.401700E-02
Normal-vs-NoPancreatitis
5.536300E-02
Pancreatitis-vs-NoPancreatitis
4.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.275610E-01
Normal-vs-N1
5.889800E-02
N0-vs-N1
8.504200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.345600E-02
Normal-vs-TP53-NonMutant
3.402800E-01
TP53-Mutant-vs-TP53-NonMutant
8.688100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
